A tale of A1298C mutation and recurrent Pulmonary Embolism: a rare association

Submitted: 9 August 2024
Accepted: 10 September 2024
Published: 17 September 2024
Abstract Views: 44
PDF: 19
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Pulmonary Embolism (PE) and Deep Venous Thrombosis (DVT) represent critical manifestations within the spectrum of Venous Thromboembolic Disease (VTE). The MTHFR A1298C gene mutation occurs in approximately 7% to 12% of individuals in North America, Europe, and Australia. It is less prevalent among Hispanic populations, with a frequency of 4% to 5%, and even lower in Chinese and Asian populations, where it ranges from 1% to 4%.

A 50-year-old male with a history of recurrent PE and long-term anticoagulation, despite effective anticoagulation, was not getting relieved. Genetic testing revealed a heterozygous MTHFR A1298C mutation which is very rare and elevated serum homocysteine levels, contributing to a hypercoagulable state. Comprehensive evaluation and management are essential to prevent further thromboembolic events in such patients.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Moll S, Varga EA. Homocysteine and MTHFR mutations. Circulation. 2015;132:e6-9.
Turetz M, Sideris AT, Friedman OA, et al. Epidemiology, pathophysiology, and natural history of pulmonary embolism. InSeminars in Interventional Radiology 2018;35:92-8.
Duffett L, Castellucci LA, Forgie MA. Pulmonary embolism: update on management and controversies. BMJ. 2020;370:m2177.
Selhub J. Homocysteine metabolism. Annual Review of Nutrition. 1999;19:217-46.
Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: an overview. Archives of Pathology & Laboratory Medicine. 2007;131:872-84.
Cortese C, Motti C. MTHFR gene polymorphism, homocysteine and cardiovascular disease. Public Health Nutrition. 2001;4:493-7.
Brustolin S, Giugliani R, Felix TM. Genetics of homocysteine metabolism and associated disorders. Brazilian Journal of Medical and Biological Research. 2010;43:1-7.
Liu F, Silva D, Malone MV, Seetharaman K. MTHFR A1298C and C677T polymorphisms are associated with increased risk of venous thromboembolism: a retrospective chart review study. Acta Haematologica. 2018;138:208-15.
Fodinger M, Mannhalter C, Wolfl G, et al. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. Kidney Int. 1997;52:517-23.
Lee HA, Choi JS, Ha KS, et al. Influence of 5,10-methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine concentration in patients with end-stage renal disease. Am. J. Kidney Dis. 1999;34:259-63.
Fodinger M, Buchmayer H, Heinz G, et al. Effect of MTHFR 1298A ! C and MTHFR 677C ! T genotypes on total homocysteine, folate, and vitamin B(12) plasma concentrations in kidney graft recipi- ents. J. Am. Soc. Nephrol. 2000;11:1918-25.
Zhang YX, Yang LP, Gai C, et al. Association between variants of MTHFR genes and psychiatric disorders: A meta-analysis. Frontiers in Psychiatry. 2022;13:976428.
More A, Gajbe U, Olatunji O, Singh B. MTHFR Gene-Polymorphism and Infertile Men in Indian Population: A Systematic Literature Review. Cureus. 2022;14:e27075.
Ginani CTA, Luz JRDD, Silva SVE, et al. Association between MTHFR C677T and A1298C gene polymorphisms and maternal risk for Down syndrome: A protocol for systematic review and/or meta-analysis. Medicine (Baltimore). 2022;101:e28293.
El-Khawaga OY, Al-Azzawy MF, El-Dawa AN, et al. Association study between genetic polymorphisms in MTHFR and stroke susceptibility in Egyptian population: a case–control study. Scientific Reports. 2024;14:114.
Kumar J, Das SK, Sharma P, et al. Homocysteine levels are associated with MTHFR A1298C polymorphism in Indian population. Journal of Human Genetics. 2005;50:655-63.

How to Cite

Vij, H., & Mehdi Rizvi , S. H. (2024). A tale of A1298C mutation and recurrent Pulmonary Embolism: a rare association. Chest Disease Reports, 12(1). https://doi.org/10.4081/cdr.12.12911